Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: FIGO 2018 Stage IIB IIIB IIIC1 IIIC2 IVA disease Age of patient 18 years or older ECOG performance status 0 2 Histological diagnosis of squamous cell carcinoma adenocarcinoma or adenosquamous cell carcinoma of the cervix Written informed consent Patient fit for brachytherapy
Exclusion criteria
Exclusion criteria: Presence of distant metastases during treatment Patients who have undergone a previous hysterectomy or will have a hysterectomy as part of their initial cervix cancer treatment Patients with other invasive malignancies who had (or have) any evidence of the other cancer present within the last 5 years Serious uncontrolled medical condition Patients who have received previous chemotherapy or pelvic radiotherapy MRI contraindicated in patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Compare dose coverage of target volumes with and without needle loading in Geneva application namely: Gross Tumor volume (GTV), High-risk Clinical target. volume (HRCTV), Intermediate-risk Clinical target volume (IRCTV). 2. Compare organs at risk doses with and without needle loading in Geneva application namely: Bladder 2cc, Rectum 2cc, and Sigmoid 2cc volumes.Timepoint: 1. One week 2. One week | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactMr Bhavesh P Bandekar
Mahamana Pandit Madan Mohan Malaviya Cancer Centre
Outcome results
None listed